HIGHLIGHTS
- who: Fangyuan Xie from the National Center for Liver Cancer, China Department of Pharmacy, Third Affiliated Hospital of Naval Medical University, Shanghai, China have published the research work: Exosomes as drug delivery system in gastrointestinal cancer, in the Journal: (JOURNAL)
- what: The research aimed at clinical transformation should make continuous efforts to improve the production, purity, targeting, and bioactivity of exosomes.
- how: The results showed that A33 antibody-functionalized exosomes had the obvious tumortargeting ability and have been confirmed to inhibit tumor growth . The results showed that engineered exosomes loaded with 5-FU . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.